I am sorry they did this to you
Lol of course you are the one to respond on this.
I am sorry they did this to you
You have something to back up your bolded statement? Because it has not been true in NJ:"Cases, as a moment’s reflection reveals, do not equal sickness, much less hospitalisations."
We've been down this road very recently in the US. And this was the exact argument, but as it turned out, and not unexpectedly, hospitalization #'s will rise in the wake of rising case #'s and deaths will follow along after that.
I understand people are tired of the shut down, and even more importantly the shut downs crippling of the economy, but would it be a better idea to be ahead of the curve or to wait until you get to the point where your hospitals are being overrun and the deaths are piling up?
Nice find. Is that Biden campaign sign on the right? (Just having a little fun):
Lol of course you are the one to respond on this.
Nice find. Is that Biden campaign sign on the right? (Just having a little fun):
You have something to back up your bolded statement? Because it has not been true in NJ:
https://www.nj.com/coronavirus/2020...en-increasing-why-arent-hospitalizations.html
In fact, the 90 day curves for hospitalizations and deaths diverge from infections, with a steady downward trend while infections are rising:
https://covidtracking.com/data/state/new-jersey
Maybe it is because NJ killed off so many of the old and infirm in the first wave and more young people are testing positive and not getting sick now?
In Arizona, however, the curves for infections, deaths and hospitalization are in sync.
https://covidtracking.com/data/state/arizona
Louie Gohmert is COVID-19-free, and he credits hydroxychloroquine
Gohmert, who turns 67 next week, told the Washington Examiner he believes his recovery was aided by the use of vitamin supplements and hydroxychloroquine, the drug touted by Trump and some medical doctors that is not endorsed by the Food and Drug Administration for use in treating the coronavirus.
“I had a couple of bad days, but I started taking hydroxychloroquine, [Zithromax], and zinc, along with vitamins D3 and C," he said. "And I took a steroid nebulizer for a few days to help coat the alveoli in the lungs and protect them somewhat from the COVID virus attack.”
He added, “I feel sorry for patients whose doctors are not even allowed to consider the hydroxychloroquine regimen. That’s a real shame.”
https://www.washingtonexaminer.com/...vid-19-free-and-he-credits-hydroxychloroquine
You are posting about Q..who looks ridiculous here?
We also know certain steroids are effective without HCQ.I think there are no tests with hydro used without steroids where it was effective
Did you read the whole thread? I know correlation does not equal causation, but the whole thread raises important questions.Ice cream causes polio
If data determines dates then why isn’t everything open?Lowest hospitalizations today since state starting tracking. Cases still up but hospitalizations way down. Why? Can’t be treatments since you need to be hospitalized for most treatments. Figure it out folks.
I'm no twitter expert but this is the top reply in the section, and it looks like it is from the guy that posted the graph.
"The goal is to keep the transmission rate below 1, which means means each new case is leading to fewer than one additional infection. Anything above that, and the virus is spreading."If data determines dates then why isn’t everything open?
Cases have been super flat for 2 months. The hospitalizations being down is likely because a younger cohort are testing positive as well as those hospitalized from early on finally getting out (or passing away).Lowest hospitalizations today since state starting tracking. Cases still up but hospitalizations way down. Why? Can’t be treatments since you need to be hospitalized for most treatments. Figure it out folks.
More ridiculousness. Case fatality ratios are very difficult to correlate to anything, given the huge variability in cases across countries. Most of those countries with high CFRs were countries that suffered the worst in the first wave, when testing was not readily available, so their cases per capita are lower, meaning their deaths per case will be artificially high. There are also many countries with low CFRs that never used HCQ (Australia, Hong Kong, Singapore off the top of my head) and they have some clear errors in the graphic (for example HCQ wasn't used in South Korea, as their huge outbreak was before HCQ was even touted as a potential cure).
Thanks, that's high praise coming from one of the top 2-3 smartest, most knowledgeable (and logical) and fairly non-partisan posters on this site. Stop by more often!In spite of all the nonsense you've had to put up with, I, and I'm guessing lots of other readers, truly appreciate your insight, dedication, and presentation of information in this thread. Good on ya, mate!
But not going to the hospital as numbers reflect."The goal is to keep the transmission rate below 1, which means means each new case is leading to fewer than one additional infection. Anything above that, and the virus is spreading."
You call 400 to 500 cases a day flat?Cases have been super flat for 2 months. The hospitalizations being down is likely because a younger cohort are testing positive as well as those hospitalized from early on finally getting out (or passing away).
If you need anything else figured out let me know.
Well if Gummibear says so that settles it!
You made the claim that pharma was all about innovation and invention. Then you list a bunch of data that doesn't support that claim. But maybe your intended point was something else.Pretty simple point. We were talking about pharma companies and I posted an article about pharma companies. Don't understand your question here.
You call 400 to 500 cases a day flat?
That is an interesting statistical point for which I do not have an answer. If the overall positive #'s are generally flat over the last 2 month why is the R over 1? I would think it would be dead flat at one as well.But not going to the hospital as numbers reflect.
SkilletBiden2, you need to reread the post I was replying to. Then comment. Thanks! But yo, still big respect to NZ for kicking lawyers to the curb.You made the claim that pharma was all about innovation and invention. Then you list a bunch of data that doesn't support that claim. But maybe your intended point was something else.
My bad for reading what you actually said.Pretty simple point. We were talking about pharma companies and I posted an article about pharma companies. Don't understand your question here.
Thanks for posting Numbers. You really don't need the second username. Your logic and facts are still faulty, but nice try!
Pharma is about innovation and invention. Fortune tracks this every year, here are the top 5 companies to watch:
Roche
Innovation Index rank: 1
Invention Index rank: 10
Number of employees: 97,735
2019 revenue: $63.638 billion
Headquarters: Basel, Switzerland
Roche has jumped seven spots from 2019 to finish first, the first time the Swiss company has done so. The company benefited from multiple clinical data wins, a pair of novel FDA approvals, and many path-leading immuno-oncology firsts by its PD-L1, Tecentriq.
AbbVie
Innovation Index rank: 2
Invention Index rank: 7
Number of employees: 30,000
2019 revenue: $32.75 billion
Headquarters: North Chicago, Ill., U.S.
Runner-up on this year’s Innovation Index (and seventh overall on the Invention ranking) is AbbVie. A model of consistency, AbbVie has held the second position two years in a row.
Novartis
Innovation Index rank: 3
Invention Index rank: 4
Number of employees: 103,914
2019 revenue: $51.9 billion
Headquarters: Basel, Switzerland
Novartis had a historic year in terms of regulatory approvals notching an unprecedented five novel drugs, helping catapult the company from ninth on the Innovation Index in 2019 to third in 2020. Notably, the company also sustained its Invention ranking—finishing fourth overall in back-to-back years, suggesting a promising future.
Vertex
Innovation Index rank: 3
Invention Index rank: 9
Number of employees: 3,000
2019 revenue: $4.164 billion
Headquarters: Boston, Mass., U.S.
With the help of the FDA approval of potential blockbuster cystic fibrosis (CF) drug Trikafta, Vertex burst onto the Innovation scale in 2019, as the best-performing biotech by far.
Eli Lilly
Innovation Index rank: 5
Invention Index rank: 3
Number of employees: 33,625
2019 revenue: $22.32 billion
Headquarters: Indianapolis, Ind., U.S.
After experiencing a jump from No. 13 in 2018 to third on the 2019 Innovation scale, Eli Lilly has settled into the fifth spot on this year’s Index. Despite the two-spot drop, Lilly’s Invention scale ranking of third for 2020 implies that the company isn’t going anywhere anytime soon.
https://fortune.com/2020/04/06/top-pharmaceutical-companies-innovation-invention-2020/
@T2Kplus10: I am not #s
Yeh I saw your reply to bac, another retread that goes like this: "...CDC made mistakes yada yada yada but Trump/Azar shoulda woulda coulda secured dual sourcing....so it's still Trump's fault..."Read the thread - I replied to bac's post last night. Try to keep up. I know it can be tough.
I know I am in there somewhere. Thanks! :Wink:Thanks, that's high praise coming from one of the top 2-3 smartest, most knowledgeable (and logical) and fairly non-partisan posters on this site. Stop by more often!
If you read his tweets, he knows what he is talking about. He is science-based, and is followed by some very prominent scientists and scholars.Well if Gummibear says so that settles it!
A frequent Fox News contributor has been hired to the task force. He is not an infectious disease doctor nor does he have public health experience, but has spoken out against lockdowns.
“Find advisors who tell you what you want to hear and confirm your views.” That’s what successful leaders always say, right?